Buprenorphine FDA Warning
The Food and Drug Administration (FDA) Issues Safety Communication for Buprenorphine On January 12th, 2022, the FDA released a safety communication warning consumers about dental problems associated with the medication buprenorphine in the orally dissolving form. What...
FDA approves new Ryaltris® Nasal Spray
What is Seasonal Allergic Rhinitis? Seasonal allergic rhinitis is also known as hay fever. It occurs because of substances in the air (such as pollen, weeds, molds, etc.), also known as allergens. Allergens cause your body to react with typical symptoms of sneezing,...
New Medication for Insomnia Approved by the FDA
On January 10th, 2022, it was announced that a new drug called QUVIVIQTM (daridorexant) was approved by the FDA (US Food and Drug Administration) for insomnia with difficulty falling asleep or staying asleep. Insomnia is a disorder making it hard to fall asleep, stay...
